Home      About this journal      Authors      Referees      Editors      Readers      Archive      Contact us
Effects of walnut kernel on the pharmacokinetics of psoralea corylifolia in rats
Hits 155  Download times 19  Received:November 10, 2025  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1673-9043.2026.03.06
Key Words   psoralea corylifolia;walnut kernel;pharmacokinetics;UHPLC-MS/MS
Author NameAffiliationE-mail
WANG Aixi Center of Drug Safety Evaluation, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
CAO Jinghao Center of Drug Safety Evaluation, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
GAO Li Center of Drug Safety Evaluation, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
WANG Jinyu Center of Drug Safety Evaluation, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
ZHANG Yue Center of Drug Safety Evaluation, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China 
 
ZHOU Kun Center of Drug Safety Evaluation, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China 
z.k.ken@263.net 
Abstract
    [Objective] This experiment aimed to investigate the effect of walnut kernel on the pharmacokinetics of Psoralea corylifolia extract in rats. [Methods] Twelve male SD rats were divided into two groups(n=6 per group):the Psoralea corylifolia group(receiving Psoralea corylifolia extract at 1.05 g/kg) and the co-administration group (receiving Psoralea corylifolia extract at 1.05 g/kg plus walnut kernel at 0.66 g/kg). Approximately 300 μL of blood was collected from the orbital venous plexus before administration(0 h) and at 12 time points post-administration. The upper plasma layer was collected and analyzed using the established method. [Results] The pharmacokinetic parameters showed that the most of the compatible rats had decreased AUC and Cmax levels, including isopsoralen, bavachinin, isobavachalcone, neobavaisoflavone and bakuchalcone. [Conclusion] This study indicates that walnut kernel can reduce the systemic exposure levels and shorten the retention time of most active components of Psoralea corylifolia in rats, thereby altering its pharmacokinetic profile. This finding provides a pharmacokinetic perspective on the potential mechanism by which walnut kernel alleviates Psoralea corylifolia-induced hepatotoxicity.

You are the 2645116 visitor.

Copyright @ 2007
Address:   Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.